arctigenin has been researched along with Cancer of Lung in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Chen, YF; He, QJ; Liu, RZ; Shao, XJ; Xiang, SF; Yang, B; Yang, YN; Ying, MD; Ying, WW; Zhang, YQ | 1 |
An, H; Chen, Y; Guo, S; Shi, S; Wang, X; Zhan, Y; Zhang, H | 1 |
Lee, SH; Lou, Z; Xu, Y | 1 |
Inafuku, M; Iwasaki, H; Oku, H; Susanti, S; Taira, N | 1 |
Jin, JJ; Wang, HQ; Wang, J | 1 |
Choi, BM; Han, YH; Hong, SH; Jeong, MY; Kee, JY; Kim, DS; Kim, HJ; Mun, JG; Park, SH; Park, SJ; Um, JY | 1 |
6 other study(ies) available for arctigenin and Cancer of Lung
Article | Year |
---|---|
Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells.
Topics: Apoptosis Regulatory Proteins; Cullin Proteins; Furans; Humans; Lung Neoplasms; NEDD8 Protein; RNA-Binding Proteins; Ubiquitin-Conjugating Enzymes | 2023 |
Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy.
Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Antineoplastic Agents; Cell Line; Furans; Humans; Lignans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C | 2020 |
Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Asteraceae; beta Catenin; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Furans; Humans; Lignans; Lung; Lung Neoplasms; Neoplasm Invasiveness; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2017 |
Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Apoptosis; Arctium; Cell Cycle Proteins; Cell Line; Cyclin E; Cyclin-Dependent Kinase 2; Cyclins; Down-Regulation; Furans; Glutathione; Humans; Lignans; Lung Neoplasms; Nuclear Proteins; Oncogene Proteins; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Signal Transduction | 2013 |
Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
Topics: Antineoplastic Agents; Base Sequence; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA Primers; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Furans; Humans; Inhibitor of Apoptosis Proteins; Lignans; Lung Neoplasms; Polymerase Chain Reaction; Survivin | 2014 |
Arctigenin Inhibits Lung Metastasis of Colorectal Cancer by Regulating Cell Viability and Metastatic Phenotypes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Female; Furans; Lignans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis | 2016 |